Amneal Pharmaceuticals Inc - Class A — datos financieros trimestrales (NASDAQ:AMRX)

Financials

Flujo de caja de las actividades operativas 118.08 M7.41 M83.82 M118.45 M130.31 M 339.99 M Flujo de caja de las actividades de inversión -16.06 M-17.8 M-26.55 M-22.46 M-45.45 M -112.26 M Flujo de caja de las actividades financieras -61.2 M-39.17 M-41.69 M59.44 M-10.12 M -31.53 M Flujo de caja libre 102.32 M-9.95 M60.09 M98.74 M105.54 M 254.41 M

Amneal Pharmaceuticals Inc - Class A

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

AMRX

Financials

Amneal Pharmaceuticals Inc - Class A

Noticias

AMRX: 3 Growth Drivers Behind Amneal's 2026 Outlook

Is AMRX Stock Undervalued? Sales Multiple, Target, Upside

Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing

Why Amneal Pharmaceuticals (AMRX) is a Top Growth Stock for the Long-Term

Amneal Pharmaceuticals: Flattish 2026 Revenue Growth Aside, Stock Still Looks A Buy (AMRX)

Amneal en la Conferencia de Barclays: Crecimiento Estratégico e Innovación

Amneal en Conferencia Barclays: Crecimiento Estratégico e Innovación

Amneal at Barclays Conference: Strategic Growth and Innovation

New Strong Buy Stocks for March 9th

Best Value Stocks to Buy for March 9th

Truist eleva el precio objetivo de Amneal Pharmaceuticals por enfoque en márgenes

Truist eleva precio objetivo de Amneal Pharmaceuticals por enfoque en márgenes